Check out this new article 📰 on CNS relapse in lymphoma patients published in @JCO_ASCO including contributions from our group and colleagues around the world 🌍
https://t.co/mSkP2O0jFW
Now available on CRAN: a new version of the ExclusionTable package 📦 which makes keeping track of your inclusion and exclusion criteria easy 🧮
The new version includes some bug fixes 🐛, and improved error messages and warnings ⚠️.
https://t.co/T3U0hkt8JN
#rstats#epitwitter
Thank you to my research group @CancerepiK and our collaborators in Sweden 🇸🇪, Denmark 🇩🇰, and Norway 🇳🇴 who made this collaborative project possible.
@ESmedby@glimelius @carolineweibull @KnutSmeland, Tarec C. El-Galaly, and Sandra Eloranta. Just to mention a few. 🧵(7/7)
Over the summer my 2. PhD project on childbearing among #NHL survivors by histological and clinical subtype in Sweden 🇸🇪, Denmark 🇩🇰, and Norway 🇳🇴 was published in @BrJHaem 🗞️. A thread 🧵(1/7)
https://t.co/erGZPGFwHw
Overall, our results convey a positive message for #NHL survivors showing overall similar childbirth patterns among #NHL survivors and comparators. Nevertheless, these results at the same time underscore the importance of fertility counselling for these patients 👩🍼🧑🍼. 🧵(6/7)
✨NOW ONLINE✨
New Nordic study by @entjos et al. highlights the need for timely fertility preservation for #Hodgkin#Lymphoma survivors, particularly males, in order to alleviate treatment effects on future childbearing
🔓OPEN ACCESS
➡️https://t.co/tS2k4ys4QW
Out today, Nordic study on reproductive patterns in #Hodgkin lymphoma survivors, reassuring fertility rates for #women, #men lagging behind, fewer children than comparators, maybe for reasons other than strict medical once? https://t.co/sG6mpRPPY2 @entjos@CancerepiK
Thank you to all collaborators across Sweden, Denmark, and Norway that made this project possible! 🧵(6/6)
@ESmedby@glimelius@Dr_Daniel_Molin @carolineweibull @KnutSmeland and others who are not on Twitter, i.a., Tarec C. El-Galaly, and Sandra Eloranta.
Fresh out of press 🗞️ in @IntJCanc, my first PhD study on childbearing among #Hodgkin#lymphoma survivors treated with BEACOPP and ABVD in Sweden 🇸🇪, Denmark 🇩🇰, and Norway 🇳🇴. A thread 🧵(1/6)
https://t.co/y1OA80kgy0
Overall, our study highlights the need for timely fertility counselling 👩⚕️👨⚕️ for #HL survivors to alleviate the impact of intensive chemotherapy treatment on future childbearing. 🧵(5/6)
Are you interested in colorectal cancer research and searching for data sources? 👨⚕️👩⚕️ If so, check out our recent publication 📰 on CRCBaSe, a Swedish colorectal cancer database 💾 including information on around 77,000 patients diagnosed between 1995 and 2016 in Sweden 🇸🇪.
Check out our new publication 🎉 "Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden" in @Hemasphere_EHA 📰! Thanks to @carolineweibull & @ESmedby who led this project 👩🔬! A 🧵(1/4)